LRN (LRN)

$3.7B
Market Cap
13.0
P/E Ratio
0.06
Beta
Dividend Yield
Piotroski 7/9Altman Z 5.6 SafeBeneish M -2.66 CleanROIC−WACC +8.0%

Quantitative Summary

Deterministic

Financial health metrics are strong: Piotroski 7/9, Altman Z 5.6 (above 3.0 safe zone threshold).

Generated deterministically from quant metrics and financial statements. Not a recommendation.

Algorithmic Teardown

AI-Generated

The fundamental economics of LRN demonstrate robust capital efficiency, evidenced by an ROIC-WACC spread of 8.0%, indicating the company consistently generates returns significantly above its cost of capital. This profitability is underpinned by a DuPont decomposition where strong gross margins at 39.2% and net margins at 12.0% drive performance, supported by accelerating revenue growth of 17.9%. Financial health metrics further validate this quality profile; the Piotroski F-Score of 7/9 signals high financial strength with minimal deterioration risk, while an Altman Z-Score of 5.6 places the firm well within safe territory regarding bankruptcy probability. Additionally, a Beneish M-Score of -2.66 suggests earnings are unlikely to be subject to manipulation, reinforcing the integrity of these reported fundamentals.

Valuation metrics present a divergence between current market pricing and intrinsic value models. Trading at 13.0x forward earnings, the stock appears compressed relative to its historical trajectory and likely below sector averages given its superior growth rate of nearly 18%. A DCF analysis implies a fair value of $431 per share; if this projection holds based on current cash flow assumptions and implied terminal growth rates, the market price may be pricing in conservative expectations or temporary headwinds rather than structural weakness. The combination of high-quality earnings generation and a valuation multiple that does not fully reflect the 8% excess return spread suggests the asset could offer compelling risk-adjusted upside potential if macro conditions stabilize.

Risk assessment indicators remain benign, with no red flags emerging from the provided data points to suggest elevated downside volatility or governance concerns. The convergence of strong profitability drivers, clean earnings quality signals, and a valuation gap between current prices and DCF estimates creates an asymmetric opportunity profile for long-term holders. However, investors must weigh whether the 13x P/E multiple already incorporates anticipated mean reversion in growth rates before committing capital based solely on these quantitative signals.

Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.

DCF Sandbox

Interactive

Sensitivity Matrix

TG ↓ / WACC →6%7.6%9.6%
2%$516$363$263
3%$669$431$295
4%$977$537$339

Center = base case. Green = >10% upside, Red = >10% downside vs .

Pre-computed DCF: WACC=7.6%, terminal growth 3%. Fair value $431 (+0.0%). Not investment advice.

Price Chart with Moving Averages

Loading chart...
SMA 50 SMA 200

Quant Health Deep Dive

7/9
Piotroski F-Score
Strong — high operational efficiency and profitability signals
5.6
Altman Z-Score
Safe Zone — above 3.0 threshold per academic model. Thresholds: >3 safe, 1.8–3 grey, <1.8 distress.
-2.66
Beneish M-Score
Below threshold — no statistical earnings quality concern per Beneish model. Threshold: <-2.22 = below threshold.

Profitability & Value Creation

39.2%
Gross Margin
12.0%
Net Margin
15.6%
ROIC
7.6%
WACC
ROIC − WACC Spread: +8.0%— Positive value creation spread.
+17.9%
Revenue Growth (YoY)
+41.0%
Earnings Growth (YoY)
372.8M
Free Cash Flow

Balance Sheet Health

0.55x
Debt / Equity
5.39x
Current Ratio
37.5x
Interest Coverage
-0.7x
Net Debt / EBITDA
11.19%
FCF Yield
508.4M
EBITDA

Earnings Surprise History

Q4
✗ Miss
Est: $2.15
Act: $2.02
-5.9%
Q3
✓ Beat
Est: $1.89
Act: $2.29
+21.4%
Q2
✓ Beat
Est: $1.26
Act: $1.52
+20.4%
Q1
✓ Beat
Est: $2.32
Act: $2.50
+7.8%

EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.

Underwater (Drawdown from Peak)

How far below the all-time high the price has been over time. Deeper = more pain for holders.

Loading drawdown chart...

Rolling 60-Day Beta vs S&P 500 (VOO)

How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.

Loading beta chart...
Rolling Beta Market (β = 1.0)

Fundamentals

9.5
Forward P/E
PEG Ratio
2.29
Price/Book
1M
Avg Volume
$171.17
52W High
$60.61
52W Low
52W Range Position

Passive Flow Attribution

ETF Draft Effect
$121M
Tracked Passive Exposure
6
ETFs Holding LRN
0.13%
Avg Weight in ETFs
$90B
Total ETF AUM

When investors buy or sell ETFs like SLYV or SPSM, the fund manager is mechanically forced to buy or sell LRN shares regardless of LRN's individual fundamentals. We estimate $121M of passive capital is structurally linked to LRN through 6 tracked ETFs. Passive flows have a limited but growing influence on LRN's daily trading dynamics.

Passive exposure = Σ (ETF AUM × stock weight in ETF) across 6 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.

ETF Contagion Visualizer

Simulate a price drop in LRN to visualize passive redemption contagion across ETFs and collateral stocks.

LRN Shock
-0%
Est. Passive Redemption
$0
Systemic Risk
STABLE
LRNEpicenterVBKETFVTWOETFSPSMETFAMZNLow RiskTSLALow RiskHDLow RiskMCDLow RiskBELow Risk
LRN Price Drop (%)0

If LRN (LRN) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies Amazon.com Inc. (AMZN) as the most exposed collateral stock, sharing 1 ETFs with LRN. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.

Contagion model based on shared ETF exposure and constituent weights across 6 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.

LRN Ownership Dynamics

Ticker
LRN

Float lock-up computed from 7 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).

LRN Capital Efficiency

How efficiently does LRN convert operating profits into free cash? The FCF Conversion ratio measures the gap between accounting earnings and real cash generation.

Free Cash Flow
$373M
EBITDA
$508M
FCF Conversion
73%
Reinvestment Rate
27%
73% of EBITDA → Free Cash
0% (cash burn)25% (low)50% (efficient)100% (pure cash)
ROIC
15.6%
ROIC − WACC Spread
8.0%

LRN converts 73% of its EBITDA into free cash flow, an exceptional conversion rate indicating an asset-light business model with minimal capital reinvestment drag. The positive ROIC-WACC spread of 8.0% confirms that reinvested capital creates shareholder value.

Capital efficiency = Free Cash Flow ÷ EBITDA. Reinvestment = (EBITDA − FCF) ÷ EBITDA. Metrics from latest annual filings. Not investment advice.

Fails-to-Deliver (FTD) History

SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.

DateFailed SharesClose PriceNotional Value
2026-05-1310,000$87.42$874,200
2026-05-1210,000$87.34$873,400
2026-05-06333$93.76$31,222.08
2026-05-05554$92.26$51,112.04
2026-05-04897$93.08$83,492.76
2026-04-2916$92.58$1,481.28
2026-04-28136$97.79$13,299.44
2026-04-24128$98.36$12,590.08
2026-04-221,499$98.11$147,066.89
2026-04-2110$98.98$989.8
2026-04-20253,151$98.44$24.9M
2026-04-17225$96.92$21,807
2026-04-14833$91.88$76,536.04
2026-04-092,074$89.82$186,286.68
2026-04-0241$88.86$3,643.26
2026-03-23882$85.06$75,022.92
2026-03-20115$87.41$10,052.15
2026-03-191,077$87.01$93,709.77
2026-03-183,625$87.08$315,665
2026-03-1713,896$82.97$1.2M
2026-03-131,359$83.85$113,952.15
2026-03-1119,775$84.60$1.7M
2026-03-045$86.65$433.25
2026-03-032,432$85.98$209,103.36
2026-03-024,081$84.38$344,354.78
2026-02-2796$85.86$8,242.56
2026-02-266,625$84.22$557,957.5
2026-02-252,759$82.84$228,555.56
2026-02-234,544$82.58$375,243.52
2026-02-13148$84.45$12,498.6

Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.

Compare LRN to Peers

Quant metrics computed deterministically from financial statements and price data. Updated: N/A.

SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.